Spain presses need for earlier HIV diagnosis
This article was originally published in Clinica
A third of all new HIV-AIDS cases and over a half of all new sexually-transmitted cases in Spain in 2000 were diagnosed too late to be treated in time to halt the development of AIDS symptoms or to take preventive measures. In the light of these findings, the health ministry is calling for more frequent testing for the condition, and not only among high-risk groups.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.